Ken Griffin Maravai Lifesciences Holdings, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	BUY	$5.11 - $8.76 $112,931 - $193,596	22,100 Added 4420.0%	22,600 $195,000
Q4 2023 Feb 14, 2024	SELL	$4.7 - $9.87 $11,280 - $23,687	-2,400 Reduced 82.76%	500 $3,000
Q3 2023 Nov 14, 2023	SELL	$9.14 - $12.85 $20,108 - $28,270	-2,200 Reduced 43.14%	2,900 $29,000
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $18,135 - $22,500	1,500 Added 41.67%	5,100 $63,000
Q1 2023 May 15, 2023	SELL	$12.99 - $16.48 $170,169 - $215,888	-13,100 Reduced 78.44%	3,600 $50,000

Q4 2022 Feb 14, 2023	SELL	$12.5 - $24.78 $38,750 - $76,818	-3,100 Reduced 15.66%	16,700 $238,000
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $199,820 - $294,589	-9,700 Reduced 32.88%	19,800 $505,000

227

135M

339K

148K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $919M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.